Report Highlights
The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.
Report Includes
- 52 data tables and 51 additional tables
- An analysis of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the market size and revenue growth prospects, along with a market share analysis by the branch of biology, deployment type, application, end user and region
- Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Information about key partnerships between cloud service providers and pharma/biotech companies and investment in the pharmaceutical R&D sector
- A relevant patent analysis, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading companies, including Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.
Report Scope
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $6.2 Billion | ||||||||||||||||
| Market size forecast | $15.6 Billion | ||||||||||||||||
| Growth rate | CAGR of 16.7% from 2025 to 2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Branch Of Biology, Deployment Type, Application, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (South America and the Middle East and Africa) | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Exponential growth of biological data necessitating scalable compute and storage.
- Rising adoption of AI and advanced analytics in biology demands high-performance cloud infrastructure.
- Collaborative research and data sharing.
- Data security and privacy.
- High costs associated with cloud implementation.
- Integration with real-world evidence and clinical data.
- Commercialization of cloud-native bioinformatics as a service.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.
Related Reports
Cloud Components and Services: Global Markets
The global market for healthcare cloud computing technologies should grow from $28.6 billion in 2019 to $48.0 billion by 2024 at a compound annual growth rate (CAGR) of 10.9% for the period of 2019-2024.
Global Markets and Technologies for Electronic Health Records
The global market for electronic health records totaled $22.0 billion in 2017 and is estimated to reach $39.1 billion by 2022, growing at a compound annual growth rate (CAGR) of 12.2% for the period of 2017-2022.
Healthcare Cloud Computing: Global Markets to 2022
The global market for cloud technologies in healthcare was $16.1 billion in 2016. The market should reach $20.2 billion in 2017 and $35.0 billion by 2022, growing at a compound annual growth rate (CAGR) of 11.6% during 2017-2022.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.
Decentralized Clinical Trials: Global Markets
The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
The global market for central nervous system (CNS) biomarkers is estimated to grow from $7.6 billion in 2025 to reach $13.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 through 2030.
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Cell and Gene Therapy Tools and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
Top Trending Reports
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Cell and Gene Therapy Tools and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
Bioprocess Filtration: Global Markets
The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.
Sustainable Biopolymers: Global Markets
The global market for bio-based sustainable biopolymers was valued at $2.9 million in 2025 and is estimated to reach $6.9 million by 2030, at a compound annual growth rate (CAGR) of 18.8% from 2025 through 2030.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Report Highlights
The global market for cloud computing applications in cell biology, genomics and drug development should grow from $2.2 billion in 2019 to $6.4 billion by 2024, with a compound annual growth rate (CAGR) of 23.4% during the period of 2019-2024.
Report Includes
- 43 data tables and 18 additional tables
- An overview of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of global and regional market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Assessment of market trends and opportunities, key developments and the impact of cloud computing technology on the biotechnology, pharmaceutical and healthcare industry verticals
- Insight into recent developments in cloud infrastructure and information pertaining to key partnerships between cloud service providers and pharma/biotech companies and investment in pharmaceutical R&D sector
- Discussion of the suppliers’ landscape, as well as the market positioning and strategies of key manufacturers and suppliers for cloud computing applications
- Review of patent applications filed regarding cloud computing technology in the U.S. healthcare sector
- Company profiles of the leading market players, including Amazon Web Services (AWS) Inc., Cisco Systems Inc., DXC Technology, Google LLC, Salesforce.com Inc., and SAP SE
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More